Open
ProCAN: Psychosis-Risk Outcomes Compound Assessment Network
Subaward MPI: Fred Sabb (MPIs: Scott Woods, Youngsun Cho, Yale University)
Grant number: U01MH137298
Funding period: 2024-2029
Funded by: NIH: National Institute of Mental Health
ProNET: Psychosis-Risk Outcomes Network
Subaward PI: Fred Sabb (PI: Scott Woods, Yale University)
Grant number: U01MH124639
Funding period: 2020-2026
Funded by: NIH: National Institute of Mental Health
A Phase 2 Multicenter, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment in Adult Participants with Schizophrenia
PI: Fred Sabb
Funded by: Eli Lilly
Grant number: N/A
Funding Period: 2025-2027
A Prospective Multicenter Study to Characterize the Natural History of Tardive Dyskinesia (TD)
PI: Fred Sabb
Funded by: Teva Pharmaceuticals Industries Ltd
Grant number: N/A
Funding period: 2023-2026
An Open Label Study to evaluate the efficacy and tolerability of Xanomeline/Trospium in First Episode/Early Phase Schizophrenia Patients
PI: Fred Sabb
Funded by: Vanguard Research Group
Grant number: N/A
Funding period: 2025-2026